New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
about
Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysisThe Dual Role of Neutrophils in Inflammatory Bowel DiseasesMeta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitisPRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort.Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?Biological therapy for ulcerative colitis: an update.
P2860
Q28067760-42015EF3-E795-41E8-BA1D-D5F9DFEA2AD8Q28080144-ABB91DD7-C0A3-45B6-AEA1-9715B7559D25Q28080984-5113D8F5-DD2C-4F92-8E39-AAFC02B08A86Q35530872-6F0BAD0D-557A-430B-96DF-072C2ED396DAQ36557868-88C8C459-10CB-486F-AB9C-42AC30AA3FF2Q38217832-0DBF00B6-A2A6-47D6-8DD6-B111B1FAB217Q38259532-E2511831-47A1-458C-AE10-54CCC32D2945
P2860
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
@en
type
label
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
@en
prefLabel
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
@en
P2860
P356
P1476
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
@en
P2093
Keith Bodger
Tamsin Gledhill
P2860
P304
P356
10.2147/BTT.S30416
P577
2013-05-23T00:00:00Z